Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 5/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6860227 | 0.85 | P2RX7 (1.00) | P2RX7ABCB11MAPK1LMNAMAPT | |
| SCHEMBL6939824 | 0.79 | P2RX7 (0.71) | P2RX7MAPK1LMNAMAPTL3MBTL1 | |
| SCHEMBL6943094 | 0.77 | P2RX7 (0.78) | P2RX7LMNAMAPTALDH1A1USP2 | |
| SCHEMBL6939157 | 0.76 | P2RX7 (0.82) | P2RX7MAPK1LMNAMAPTL3MBTL1 | |
| SCHEMBL6941644 | 0.75 | P2RX7 (1.00) | P2RX7MAPK1LMNAMAPTL3MBTL1 | |
| SCHEMBL5515290 | 0.74 | P2RX7 (0.64) | P2RX7MAPK1LMNAMAPTNPSR1 | |
| SCHEMBL6943104 | 0.72 | P2RX7 (0.76) | P2RX7ABCB11MAPK1NPSR1 | |
| SCHEMBL6939404 | 0.72 | P2RX7 (0.72) | P2RX7ABCB11MAPK1NPSR1 | |
| SCHEMBL6939407 | 0.71 | P2RX7 (0.72) | P2RX7ABCB11 | |
| SCHEMBL7956634 | 0.71 | P2RX7 (0.72) | P2RX7ABCB11MAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036058-B1 | ADAMANTANE DERIVATIVES | ASTRAZENECA UK LTD (GB) | 2003-03-12 | — | — | EP | claimed |
| US-6242470-B1 | RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS, ANTIALLERGENS; IRRITABLE BOWEL SYNDROME; AMIDATION | ASTRAZENECA AB (SE) | 2001-06-05 | — | — | US | claimed |
| EP-1036058-B1 | ADAMANTANE DERIVATIVES | ASTRAZENECA UK LTD (GB) | 2003-03-12 | — | — | EP | disclosed |
| US-6242470-B1 | RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS, ANTIALLERGENS; IRRITABLE BOWEL SYNDROME; AMIDATION | ASTRAZENECA AB (SE) | 2001-06-05 | — | — | US | disclosed |
| EP-1036058-A1 | ADAMANTANE DERIVATIVES | AstraZeneca UK Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029660-A1 | ADAMANTANE DERIVATIVES | ASTRAZENECA UK LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |